The UK Vaccine Minister Nadhim Zahawi has said he received a recommendations from the Joint Committee on Vaccination and Immunisation (JCVI) about whether to recommend vaccines for under-18s, BBC News reported on Monday.
Zahawi told BBC Breakfast he will make a statement to Parliament later, but he says the JCVI has recommended that children with medical conditions that make them vulnerable to COVID-19 should be vaccinated, along with those who live with clinically vulnerable people.
He also said the committee recommends that children close to their 18th birthday should have the vaccine.
However, the JCVI will be keeping under review whether or not to vaccinate healthy children aged 12 to 17.
Reportedly, the committee is concerned about some data suggesting there may be rare cases of myocarditis, an inflammation of the heart muscle, linked to the vaccine.
Innovent and Ollin Biosciences report IBI324 study data in wAMD and DME
Boston Scientific receives FDA clearance for Asurys fluid management system
Lilly presents Phase 3b Taltz (ixekizumab) plus Zepbound (tirzepatide) data at AAD Annual Meeting
Hoth Therapeutics deploys OpenClaw AI platform for drug discovery
Thermo Fisher Scientific and SHL Medical launch integrated US drug-device manufacturing
Bambusa Therapeutics names new CFO
Mabtech partners with Sai Life Sciences to expand access to EYRA multiplex immunology platform
Vimgreen Pharmaceuticals receives IND clearance for VG081821 in China
Inimmune reports dosing of first patient in Phase 2 allergen challenge chamber trial of INI-2004
Gesynta Pharma doses first patient in vipoglanstat Phase 2 clinical proof-of-concept trial
Immunic granted European patent for vidofludimus calcium dosing regimens
Biofrontera reports Phase 2b data for Ameluz photodynamic therapy in acne vulgaris treatment